Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Clearing the smoke around the TB-HIV syndemic: smoking as a critical issue for TB and HIV treatment and care
  • Published Date:
    Sep 2015
  • Source:
    Int J Tuberc Lung Dis. 19(9):1003-1006
  • Language:
    English
Filetype[PDF-74.96 KB]


Details:
  • Alternative Title:
    Int J Tuberc Lung Dis
  • Personal Author:
  • Description:
    The collision of the tuberculosis (TB) and human immunodeficiency virus (HIV) epidemics has been described as a 'syndemic' due to the synergistic impact on the burden of both diseases. This paper explains the urgent need for practitioners and policy makers to address a third epidemic that exacerbates TB, HIV and TB-HIV. Tobacco use is the leading cause of preventable death worldwide. Smoking is more prevalent among persons diagnosed with TB or HIV. Smoking is associated with tuberculous infection, TB disease and poorer anti-tuberculosis treatment outcomes. It is also associated with an increased risk of smoking-related diseases among people living with HIV, and smoking may also inhibit the effectiveness of life-saving ART. In this paper, we propose integrating into TB and HIV programmes evidence-based strategies from the 'MPOWER' package recommended by the World Health Organization's Framework Convention on Tobacco Control. Specific actions that can be readily incorporated into current practice are recommended to improve TB and HIV outcomes and care, and reduce the unnecessary burden of death and disease due to smoking.

  • Subject:
  • Pubmed ID:
    26260816
  • Pubmed Central ID:
    PMC4752114
  • Document Type:
    Journal Article
  • Funding:
    CC999999/Intramural CDC HHS/United States
  • Place as Subject:
    United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. MMWR. Morbidity and mortality weekly report, Vol. 63, no. 47, November 28, 2014
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    November 28, 2014
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 63, no. 47
    File Type:
    Filetype[PDF - 809.26 KB]
  2. MMWR. Morbidity and mortality weekly report, Vol. 61, no. 26, July 6, 2012
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    July 6, 2012
    Series:
    MMWR. Morbidity and mortality weekly report ; v. 61, no. 26
    File Type:
    Filetype[PDF - 841.38 KB]
  3. HIV-Associated TB in An Giang Province, Vietnam, 2001–2004: Epidemiology and TB Treatment Outcomes
    Personal Author:
    Thuy, Trinh Thanh; Shah, N. Sarita; Anh, Mai Hoang; Nghia, Do Trong; Thom, Duong; Linh, Truong; Sy, Dinh Ngoc; Duong, Bui Duc; Chau, Luu Thi Minh; Mai, Phung Thi Phuong; Wells, Charles D.; Laserson, Kayla F.; Varma, Jay K.;
    Published Date:
    Jun 06 2007
    Source:
    PLoS ONE. 2007; 2(6).
    Description:
    BackgroundMortality is high in HIV-infected TB patients, but few studies from Southeast Asia have documented the benefits of interventions, such as co-trimoxazole (CTX), in reducing mortality during TB treatment. To help guide policy in Vietnam, we s...
    File Type:
    Filetype[PDF - 112.03 KB]
  4. Antiretroviral Therapy during Tuberculosis Treatment and Marked Reduction in Death Rate of HIV-Infected Patients, Thailand1
    Personal Author:
    Akksilp, Somsak; Karnkawinpong, Opart; Wattanaamornkiat, Wanpen; Viriyakitja, Daranee; Monkongdee, Patama; Sitti, Walya; Rienthong, Dhanida; Siraprapasiri, Taweesap; Wells, Charles D.; Tappero, Jordan W.; Varma, Jay K.;
    Published Date:
    Jul 2007
    Source:
    Emerg Infect Dis. 13(7):1001-1007.
    Description:
    Antiretroviral therapy (ART) is lifesaving in patients with advanced HIV infection, but the magnitude of benefit in HIV-infected patients receiving tuberculosis (TB) treatment remains uncertain, and population-based data from developing countries are...
    File Type:
    Filetype[PDF - 102.99 KB]
  5. Centers for Disease Control and Prevention justification of appropriation estimates for Appropriations Committees fiscal year 2009
    Personal Author:
    Gerberding, Julie L.
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    2/11/2008
    Description:
    As the Director of the Centers for Disease Control and Prevention and the Administrator of the Agency for Toxic Substances and Disease Registry, it is my pleasure to present the agency’s budget request for Fiscal Year (FY) 2009. In response to the ...
    File Type:
    Filetype[PDF - 6.61 MB]